Ikhaya Broilers Business Plan
Protein, produced locally — a commercial broiler enterprise. Four tunnel-ventilated houses · 560,000 birds a year · contract & independent offtake · Land…
Ikhaya Broilers
Protein, produced locally — a commercial broiler enterprise
Four tunnel-ventilated houses · 560,000 birds a year · contract & independent offtake · Land Bank Blended Finance · 100% Black-owned, Level 1 — Bergville · KwaZulu-Natal · South Africa.
Ikhaya Broilers is raising a R26.0 million total project — R5.2 million of sponsor equity alongside a R14.3 million senior term loan and a R6.5 million blended-finance grant — to establish a start-up commercial broiler enterprise near Bergville, KwaZulu-Natal. Four tunnel-ventilated houses will produce 560,000 birds a year under contract and independent offtake, structured for Land Bank Blended Finance and 100% Black-owned at Level 1 contributor status. Headline revenue and EBITDA are preserved exactly; everything below EBITDA is independently re-derived (component depreciation, full cash interest, 27% SA tax with assessed-loss relief, working capital) with the balance sheet tying to zero every year. This plan sets out the market and industry analysis, disease risk, vaccination and biosecurity, the production model, unit economics, market access and offtake, input supply and procurement, operations and organisation, transformation, community and ESG, the funding structure and use of funds, a capital adequacy review, the implementation programme, competitive positioning, full financial projections, debt-service coverage and break-even, returns and sensitivities, risk analysis and independent findings, the SWOT and strategic analysis, the growth path and exit, and the key performance indicators funders will track. Use the contents below to navigate the plan.
Financial snapshot
Two headline charts from the plan. Full projections and all visualisations are in Section 15: Financial Plan & Projections.
Contents
22 sections. Each opens on its own page with previous / next navigation and a jump-to-section menu.
iImportant Notice & DisclaimerPlease read before reviewing the plan →
- 1Executive Summary
- 2Company Overview & Governance
- 3Market & Industry Analysis
- 4Disease Risk, Vaccination & Biosecurity
- 5Production Model
- 6Unit Economics
- 7Market Access & Offtake
- 8Input Supply & Procurement
- 9Operations & Organisation
- 10Transformation, Community & ESG
- 11Funding Structure & Use of Funds
- 12Capital Adequacy Review
- 13Implementation Programme
- 14Competitive Positioning
- 15Financial Plan & Projections
- 16Debt Service Coverage & Break-Even
- 17Returns, Scenarios & Sensitivity
- 18Risk Analysis & Independent Findings
- 19SWOT & Strategic Analysis
- 20Growth Path & Exit
- 21Key Performance Indicators
- 22Conclusion & The Funding Ask
- Annexure AAnnexure A: Detailed Financial Statements
- Annexure BAnnexure B: Assumptions Book
- Annexure CAnnexure C: Scenario & Sensitivity Detail
- Annexure DAnnexure D: Cycle Budget
- Annexure EAnnexure E: Regulatory & Compliance Register
- Annexure FAnnexure F: Biosecurity & Veterinary Programme
- Annexure GAnnexure G: Detailed Risk Register
- Annexure HAnnexure H: Funding Application Checklist
- Annexure IAnnexure I: Glossary & Funder Questions